Neurotic disorder, headache, and stress: experience of managing a comorbid patient and the role of magnesium drugs

In the practice of neurologists and therapists, patients with complaints of headache, increased fatigue, and irritability are common. The most frequent causes of headaches in ambulatory patients are primary headaches (migraine and tension headaches). Lack of sleep, stress, symptoms of anxiety and depression, and abuse of analgesic drugs are the most common factors that contribute to the frequency of headaches. Magnesium deficiency is another factor, the role of which has been discussed in the frequency of primary headaches, in the development of neurotic disorders and depression. Clinical manifestations of magnesium deficiency itself usually include such nonspecific symptoms as fatigue, anxiety, irritability, numbness in the extremities, leg cramps, sleep disorders, etc.
Magnesium deficiency is widespread among the population of developed countries, especially among women of reproductive age, often occurs during pregnancy, while taking oral contraceptives. Magnesium is involved in the regulation of the nervous system, neuromuscular transmission, cardiac activity, regulation of vascular tone, blood clotting and bone tissue metabolism. Magnesium deficiency is associated with diseases such as coronary heart disease, hypertension, type 2 diabetes, Alzheimer’s disease, migraine, osteoporosis, depression, neurotic disorders (panic disorder, generalized anxiety, various phobias), and fibromyalgia syndrome. Stress can lead to a decrease in magnesium levels in the body, and magnesium deficiency, in turn, reduces tolerance to stressful situations. Timely diagnosis and adequate treatment of magnesium deficiency and associated conditions represent important clinical challenges.
The clinical case of a patient with neurotic disorder, headache and magnesium deficiency is presented, and the effectiveness of an interdisciplinary approach including an educational talk, adequate therapy for headache management, magnesium drug therapy and psychological methods is demonstrated. The role of magnesium deficiency in the development of various neurologic diseases is reviewed. The most effective magnesium compounds for therapy are discussed. Principles of diagnosis and treatment of patients with magnesium deficiency are presented.

1. Parfenov V.A., Golovacheva V.A. Chronic pain and its treatment in neurology. Moscow: GEOTAR-Media; 2018. 288 p. (In Russ.).

2. Osipova V.V., Tabeeva G.R. Primary headaches. Moscow: PAGRI-Print; 2007. 60 p. (In Russ.).

3. Tabeeva G.R., Yahno N.N. Migraine. Moscow: GEOTAR-Media; 2011. 624 p. (In Russ.).

4. Golovacheva V.A., Parfenov V.A., Tabeeva G.R., Osipova V.V., Smulevich A.B., Andryushchenko A.V., Golovacheva A.A. The optimization of management of chronic daily headache patients. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2):4–9. (In Russ.) doi: 10.17116/jnevro2017117214-9.

5. Gröber U., Schmidt J., Kisters K. Magnesium in Prevention and Therapy. Nutrients. 2015;7(9):8199–8226. doi: 10.3390/nu7095388.

6. Dadak K. Magnesium deficiency in obstetrics and gynecology. Akuserstvo, ginekologia i reprodukcia = Obstetrics, Gynecology and Reproduction. 2013;7(2):6–14. (In Russ.) Available at: https://gynecology.su/jour/article/view/13?locale=ru_RU.

7. Blinov D.V., Ushakova T.I., Makatsariya N.A., Khamani N.M., Bitsadze V.O., Dadak C. Hormonal Contraception and Magnesium Deficiency: a subanalysis of the MAGYN Study. Akuserstvo, ginekologia i reprodukcia = Obstetrics, Gynecology and Reproduction. 2017;11(1):36–48. (In Russ.) doi: 10.17749/2313-7347.2017.11.1.036-048.

8. Дефицит магния в акушерстве и гинекологии: результаты национального совещания. Akuserstvo, ginekologia i reprodukcia = Obstetrics, Gynecology and Reproduction. 2014;8(2):6–10. (In Russ.) Available at: https://gynecology.su/jour/article/view/76?locale=ru_RU.

9. Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res. 2001;14(4):283–290. Available at: https://pubmed.ncbi.nlm.nih.gov/11794636/.

10. Mohammad-Alizadeh-Charandabi S., Mirghafourvand M., Froghy L., Javadzadeh Y., Razmaraii N. The effect of multivitamin supplements on continuation rate and side effects of combined oral contraceptives: A randomised controlled trial. Eur J Contracept Reprod Health Care. 2015;20(5):361–371. doi: 10.3109/13625187.2015.1010115.

11. Nazarenko E.G. Magnesium and female reproductive system. Meditsinskiy sovet = Medical Council. 2019;(7):119–125. (In Russ.) doi: 10.21518/2079701X-2019-7-119-125.

12. Ismail Y., Ismail A.A., Ismail A.A.A. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med. 2010;48(3):323–327. doi: 10.1515/CCLM.2010.077.

13. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3 rd ed. Cephalalgia. 2018;38(1):1–211. doi: 10.1177/0333102417738202.

14. Filatova E.G., Osipova V.V., Tabeeva G.R., Parfenov V.A., Ekusheva E.V., Azimova Yu.E. et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) doi: 10.14412/2074-2711-2020-4-4-14.

15. Bendtsen L., Evers S., Linde M., Mitsikostas D.D., Sandrini G., Schoenen J. EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur J Neurol. 2010;17(11):1318–1325. doi: 10.1111/j.1468-1331.2010.03070.x.

16. Mangolini V.I., Andrade L.H., Lotufo-Neto F., Wang Y.P. Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence. Clinics (Sao Paulo). 2019;74:e1316. doi: 10.6061/clinics/2019/e1316.

17. Ismail A.A.A., Ismail Y., Ismail A.A. Chronic magnesium deficiency and human disease; time for reappraisal? QJM. 2018;111(11):759–763. doi: 10.1093/qjmed/hcx186.

18. Akarachkova E.S. Evaluation of the effectiveness of Magne B6 administration in patients with clinical manifestations of stress. Trudnyy patsient = Difficult Patient. 2008;6(2–3):43–46. (In Russ.) Available at: https://elibrary.ru/item.asp?id=16898174.

19. Simkin D.R., Black N.B. Meditation and mindfulness in clinical practice. Child Adolesc Psychiatr Clin N Am. 2014;23(3):487–534. doi: 10.1016/j.chc.2014.03.002.

20. Omidi A., Zargar F. Effect of mindfulness-based stress reduction on pain severity and mindful awareness in patients with tension headache: a randomized controlled clinical trial. Nurs Midwifery Stud. 2014;3(3):e21136. doi: 10.17795/nmsjournal21136.

21. Osipova V.V., Azimova Yu.E., Tabeeva G.R., Tarasova S.A., Amelin A.V., Kutsemelov I.V. et al. Diagnostics of headache in Russia and post-Soviet countries: state of the problem and ways for its solution. Annaly klinicheskoy i eksperimental’noy nevrologii = Annals of Clinical and Experimental Neurology. (2012;6(2):16–22. (In Russ.) Available at: https://cyberleninka.ru/article/n/diagnostika-golovnyh-boley-v-rossii-i-stranah-postsovetskogo-prostranstva-sostoyanie-problemy-i-puti-ee-resheniya.

22. Lebedeva E.R., Kobzeva N.R., Gilev D.V., Olesen E. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(1):19–26. (In Russ.) doi: 10.14412/2074-2711-2015-1-19-26.

23. Trisvetova E.L. Magnesium in Clinical Practice. Ratsionalnaya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2012;8(4):545–553. (In Russ.) doi: 10.20996/1819-6446-2012-8-4-258-261.

24. Dikke G.B. Elementary metabolomics and affordable tools for screening, diagnosis and treating hypomagnesemia in pregnancy. Meditsinskiy sovet = Medical Council. 2020;(3):10–16. (In Russ.) doi: 10.21518/2079-701X-20203-10-16.

25. Robertson A., Tirado C., Lobstein T., Jermini M., Knai C., Jensen J.H. et al. (eds.). Food and Health in Europe: a new basic for action. Available at: https://euro.who.int/ru/publications/abstracts/food-and-health-in-europea-new-basis-for-action.

26. Guo W., Nazim H., Liang Z., Yang D. Magnesium deficiency in plants: An urgent problem. Crop J. 2016;4(2):83–91. doi: 10.1016/j.cj.2015.11.003.

27. Workinger J.L., Doyle R.P., Bortz J. Challenges in the Diagnosis of Magnesium Status. Nutrients. 2018;10(9):1202. doi: 10.3390/nu10091202.

28. Botturi A., Ciappolino V., Delvecchio G., Boscutti A., Viscardi B., Brambilla P. The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review. Nutrients. 2020;12(6):1661. doi: 10.3390/nu12061661.

29. Costello R.B., Elin R.J., Rosanoff A., Wallace T.C., Guerrero-Romero F., Hruby A. et al. Perspective: the case for an evidence-based reference interval for serum magnesium: The time has come. Adv Nutr. 2016;7(6):977–993. doi: 10.3945/an.116.012765.

30. Gums J.G. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm. 2004;61(15):1569–1576. doi: 10.1093/ajhp/61.15.1569.

31. Orlova S., Dikke G., Pickering G., Konchits S., Starostin K., Bevz A. Magnesium Deficiency Questionnaire: A New Non-Invasive Magnesium Deficiency Screening Tool Developed Using Real-World Data from Four Observational Studies. Nutrients. 2020;12(7):2062. doi: 10.3390/nu12072062.

32. Makatsariya A.D., Bitsadze V.O., Khizroeva D.Kh., Dzhobava E.M. Prevalence of magnesium deficiency in pregnant women. Voprosy ginekologii, akusherstva i perinatologii = Gynecology, Obstetrics and Perinatology. 2012;11(5):25–35. (In Russ.) Available at: https://elibrary.ru/item.asp?id=18759378.

33. Barsuk A.L. Bioavailability of oxide and other magnesium compounds in oral administration (review). RMZh = RMJ. 2014;(2):134. (In Russ.) Available at: https://rmj.ru/articles/obshchie-stati/Biodostupnosty_oksida_i_drugih_soedineniy_magniya_pri_peroralynom_prieme_obzor/.

34. Spasov A.A., Petrov V.I, Iezhitsa I.N., Kravchenko M.S., Kharitonova M.V., Ozerov A.A. Comparative study of magnesium salts bioavailability in rats fed a magnesium-deficient diet. Vestnik Rossiiskoi akademii meditsinskikh nauk = Annals of the Russian Academy of Medical Sciences. 2010;(2):29–37. (In Russ.) Available at: https://elibrary.ru/item.asp?id=14307643.

35. Akarachkova E.S. Application of Magne B6 in therapeutic practice. Trudnyy patsient = Difficult Patient. 2007;5(5):48–56. (In Russ.) Available at: https://cyberleninka.ru/article/n/primenenie-magne-v6-v-terapevticheskoy-praktike.

36. Khashukoeva A.Z., Agaeva Z.A., Agaeva M.I., Sukhova T.N., Moseshvili G.G., Nurbekova Z.K. The role of magnesium in the treatment of symptoms climacteric syndrome. Meditsinskiy sovet = Medical Council. 2018;(21):162–166. (In Russ.) doi: 10.21518/2079-701X-2018-21-162-166.

37. Mauskop A., Altura B.T., Cracco R.Q., Altura B.M. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996;36(3):154–160. doi: 10.1046/j.1526-4610.1996.3603154.x.

38. Mauskop A., Altura B.T., Cracco R.Q., Altura B.M. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache. 1995;35(10):597–600. doi: 10.1111/j.1526-4610.1995.hed3510597.x.

39. Peikert A., Wilimzig C., Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–263. doi: 10.1046/j.1468-2982.1996.1604257.x.

40. Gaul C., Diener H.C., Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516. doi: 10.1186/s10194-015-0516-6.